Inogen Releases First Quarter 2014 Financial Results
GlobeNewswire - Tue May 13, 3:09PM CDT
- Strong Q1 2014 Revenue Growth of 50% Year-over-Year -
Inogen to Release First Quarter 2014 Financial Results and Host Conference Call on Tuesday, May 13, 2014
GlobeNewswire - Tue Apr 29, 3:46PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the home care setting, announced today that it will release its financial results for the first quarter of 2014 after the close of trading on Tuesday, May 13, 2014. The company will host a corresponding conference call beginning at 1:30pm Pacific Time/4:30pm Eastern Time.
Inogen Added to Russell 2000(R) and 3000(R) Indexes
GlobeNewswire - Mon Mar 31, 4:20PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, announced today the company was added to the Russell 2000(R) and Russell 3000(R) Indexes following the reconstitution of Russell Investment Group's family of US indexes after market close on March 31, 2014.
Inogen Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook
GlobeNewswire - Thu Mar 27, 3:12PM CDT
- Strong Q4 2013 Revenue Growth of 43% Year over Year -
Inogen Gains In Oxygen Therapy By Making Innovations
at Investor's Business Daily - Wed Mar 26, 3:16PM CDT
Portable oxygen concentrator maker Inogen, a recent IPO, isn't content being the leader in its market as a result of the lightweight, quiet and efficient technology it's incorporating into its products. It's also at the forefront of a whole industry...
Great New Product Fuels Growth At New Issue Inogen
at Investor's Business Daily - Fri Mar 14, 4:16PM CDT
The N in CAN SLIM stands for something new, and small-cap Inogen (INGN) has it. When a new issue debuts in Stock Spotlight, it's worth noting. The company makes portable oxygen machines used to deliver oxygen therapy to patients with chronic...
Inogen to Release Fourth Quarter 2013 Financial Results and Host Conference Call on Thursday, March 27, 2014
GlobeNewswire - Wed Mar 12, 3:13PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the home care setting, announced today that it will release its financial results for the fourth quarter of 2013 after the close of trading on Thursday, March 27, 2014. The company will host a corresponding conference call beginning at 1:30pm Pacific Time/4:30pm Eastern Time.
Inogen concludes IPO at USD16.00 per share
M2 - Fri Feb 21, 6:32AM CST
Oxygen therapy company Inogen (Nasdaq GS:INGN) reported on Thursday the completion of an initial public offering of 4,411,763 shares of its common stock at USD16.00 per share.
Inogen Announces Closing of Initial Public Offering
GlobeNewswire - Thu Feb 20, 4:01PM CST
Inogen, Inc. (Nasdaq:INGN) today announced that it has closed its previously announced initial public offering of 4,411,763 shares of its common stock at a price to the public of $16.00 per share. In connection with the initial public offering, Inogen offered 3,529,411 shares of common stock and certain selling stockholders offered 882,352 shares of common stock. Inogen will not receive any proceeds from the sale of shares by selling stockholders. In addition, certain selling stockholders granted the underwriters a 30-day option to purchase up to 661,764 additional shares of common stock at the initial public offering price, which the underwriters have not yet exercised. The shares of common stock are traded on The NASDAQ Global Select Market under the symbol "INGN."
NASDAQ Welcomes Inogen, Inc (NASDAQ:INGN) to the NASDAQ Stock Market
GlobeNewswire - Fri Feb 14, 10:15AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Inogen, Inc (Nasdaq:INGN), a leading medical technology company that develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, commenced on The NASDAQ Global Select Market on February 14, 2014.
Inogen Announces Pricing of Initial Public Offering
GlobeNewswire - Thu Feb 13, 10:45PM CST
Inogen, Inc. (Nasdaq:INGN) today announced the pricing of its initial public offering of 4,411,763 shares of its common stock at a price to the public of $16.00 per share. Inogen is offering 3,529,411 shares of common stock and certain selling stockholders are offering 882,352 shares of common stock. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to 661,764 additional shares of common stock at the initial public offering price. The shares are expected to begin trading on The NASDAQ Global Select Market on February 14, 2014, under the symbol "INGN".